Safety of Eptifibatide in Subarachnoid Hemorrhage Patients Requiring Antiplatelet Agents. (P2.285)

Conclusions:Our results indicate that administering IV Eptifibatide to prevent thrombotic complications after endovascular coil embolization in selected patients with aneurysmal subarachnoid hemorrhage is safe. Multicenter prospective trials are warranted to corroborate our findings.Disclosure: Dr. Mehta has nothing to disclose. Dr. Song has nothing to disclose. Dr. DeCarvalho has nothing to disclose. Dr. Z Arango has nothing to disclose. Dr. Kulhari has nothing to disclose. Dr. Kirmani has nothing to disclose.

Source: Neurology - April 17, 2017 Category: Neurology Authors: Mehta, S., Song, Y.-B., DeCarvalho, B., Arango, A. Z., Kulhari, A., Kirmani, J. F. Tags: Subarachnoid Hemorrhage, Intracranial Aneurysm, and Other Cerebrovascular Malformations Source Type: research